Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 9 | 2025 | 2021 | 0.590 |
Why?
|
Drug-Eluting Stents | 4 | 2016 | 681 | 0.570 |
Why?
|
Graft Occlusion, Vascular | 2 | 2010 | 538 | 0.520 |
Why?
|
Stents | 5 | 2023 | 3193 | 0.390 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2022 | 1564 | 0.390 |
Why?
|
Acute Coronary Syndrome | 4 | 2012 | 2193 | 0.370 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4892 | 0.350 |
Why?
|
Defibrillators, Implantable | 2 | 2009 | 1499 | 0.320 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2010 | 1721 | 0.310 |
Why?
|
Peripheral Arterial Disease | 4 | 2024 | 1304 | 0.310 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2009 | 148 | 0.310 |
Why?
|
Pulsatile Flow | 1 | 2009 | 318 | 0.300 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 210 | 0.290 |
Why?
|
Drugs, Investigational | 1 | 2010 | 211 | 0.290 |
Why?
|
Iliac Artery | 2 | 2023 | 344 | 0.270 |
Why?
|
Mitral Valve Insufficiency | 3 | 2021 | 1414 | 0.270 |
Why?
|
Anticoagulants | 4 | 2020 | 4854 | 0.270 |
Why?
|
Coronary Restenosis | 1 | 2009 | 396 | 0.260 |
Why?
|
Dyspnea | 4 | 2007 | 1352 | 0.260 |
Why?
|
Electric Countershock | 1 | 2009 | 534 | 0.250 |
Why?
|
Peptide Fragments | 4 | 2007 | 5141 | 0.250 |
Why?
|
Electrocardiography | 4 | 2021 | 6409 | 0.240 |
Why?
|
Embolic Protection Devices | 1 | 2025 | 43 | 0.240 |
Why?
|
Neck | 1 | 2009 | 736 | 0.230 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2007 | 1749 | 0.230 |
Why?
|
Ankle Brachial Index | 1 | 2024 | 163 | 0.220 |
Why?
|
Mitral Valve | 3 | 2021 | 1475 | 0.210 |
Why?
|
Plaque, Atherosclerotic | 2 | 2013 | 1549 | 0.210 |
Why?
|
Thrombosis | 4 | 2021 | 2954 | 0.210 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11513 | 0.200 |
Why?
|
Septal Occluder Device | 2 | 2020 | 126 | 0.190 |
Why?
|
Troponin T | 1 | 2007 | 786 | 0.190 |
Why?
|
Ischemic Attack, Transient | 2 | 2021 | 874 | 0.190 |
Why?
|
Angiodysplasia | 1 | 2021 | 22 | 0.190 |
Why?
|
Atrioventricular Block | 1 | 2023 | 141 | 0.180 |
Why?
|
Embolism, Paradoxical | 1 | 2021 | 55 | 0.180 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2010 | 2764 | 0.180 |
Why?
|
Prosthesis Design | 2 | 2023 | 2120 | 0.180 |
Why?
|
Orbital Pseudotumor | 1 | 2020 | 42 | 0.180 |
Why?
|
Tachycardia, Ventricular | 1 | 2009 | 1313 | 0.170 |
Why?
|
Vascular Patency | 1 | 2023 | 915 | 0.170 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2020 | 86 | 0.170 |
Why?
|
Blood Platelets | 2 | 2010 | 2464 | 0.160 |
Why?
|
Mortality | 2 | 2021 | 2909 | 0.160 |
Why?
|
Nephritis, Interstitial | 1 | 2020 | 157 | 0.160 |
Why?
|
Transposition of Great Vessels | 1 | 2023 | 581 | 0.160 |
Why?
|
Tomography, Optical Coherence | 4 | 2013 | 2954 | 0.160 |
Why?
|
Renal Dialysis | 1 | 2009 | 1790 | 0.160 |
Why?
|
Coronary Artery Disease | 6 | 2016 | 6573 | 0.160 |
Why?
|
Angioplasty, Balloon | 1 | 2023 | 592 | 0.160 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 1337 | 0.160 |
Why?
|
Lacrimal Apparatus | 1 | 2020 | 224 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2021 | 3234 | 0.150 |
Why?
|
Device Removal | 1 | 2023 | 643 | 0.150 |
Why?
|
Atrial Fibrillation | 3 | 2019 | 5180 | 0.150 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 342 | 0.150 |
Why?
|
Thrombectomy | 2 | 2015 | 676 | 0.150 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2020 | 145 | 0.150 |
Why?
|
Coronary Vessels | 4 | 2013 | 3114 | 0.150 |
Why?
|
Extracorporeal Circulation | 2 | 2015 | 182 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 956 | 0.150 |
Why?
|
Diabetic Angiopathies | 2 | 2013 | 806 | 0.150 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 828 | 0.140 |
Why?
|
Patient Readmission | 3 | 2020 | 3283 | 0.140 |
Why?
|
Coronary Angiography | 4 | 2020 | 4525 | 0.140 |
Why?
|
Hospital Mortality | 6 | 2021 | 5345 | 0.140 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1738 | 0.140 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2017 | 2144 | 0.130 |
Why?
|
Atrial Appendage | 1 | 2019 | 285 | 0.130 |
Why?
|
Aortic Valve | 3 | 2022 | 1968 | 0.120 |
Why?
|
Aged | 26 | 2025 | 171319 | 0.120 |
Why?
|
Time Factors | 13 | 2024 | 40154 | 0.120 |
Why?
|
Perception | 1 | 2001 | 1205 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2023 | 65295 | 0.120 |
Why?
|
Heparin | 2 | 2020 | 1636 | 0.120 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2023 | 1456 | 0.120 |
Why?
|
Humans | 55 | 2025 | 767040 | 0.120 |
Why?
|
Registries | 6 | 2020 | 8351 | 0.110 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
Preventive Health Services | 1 | 2018 | 570 | 0.110 |
Why?
|
Coronary Circulation | 1 | 2020 | 1603 | 0.110 |
Why?
|
Male | 36 | 2025 | 364203 | 0.110 |
Why?
|
Heart Failure | 5 | 2020 | 11877 | 0.110 |
Why?
|
Warfarin | 2 | 2019 | 1493 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3112 | 0.100 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4401 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15424 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1905 | 0.100 |
Why?
|
Vena Cava, Inferior | 1 | 2015 | 463 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1514 | 0.100 |
Why?
|
Catheterization, Peripheral | 2 | 2015 | 346 | 0.100 |
Why?
|
Neointima | 1 | 2012 | 133 | 0.090 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2011 | 61 | 0.090 |
Why?
|
Multivariate Analysis | 6 | 2021 | 12069 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 2 | 2009 | 1567 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7435 | 0.090 |
Why?
|
Takayasu Arteritis | 1 | 2012 | 106 | 0.090 |
Why?
|
Stroke | 3 | 2025 | 9746 | 0.090 |
Why?
|
Female | 35 | 2025 | 396660 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.090 |
Why?
|
Europe | 2 | 2025 | 3432 | 0.090 |
Why?
|
Aged, 80 and over | 13 | 2025 | 59548 | 0.080 |
Why?
|
Heart Valve Prosthesis | 1 | 2018 | 1464 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1481 | 0.080 |
Why?
|
Influenza, Human | 1 | 2021 | 1543 | 0.080 |
Why?
|
Angioplasty | 1 | 2012 | 355 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1946 | 0.080 |
Why?
|
Rupture | 1 | 2010 | 444 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1604 | 0.080 |
Why?
|
Sarcomeres | 1 | 2011 | 379 | 0.080 |
Why?
|
Aorta, Abdominal | 1 | 2011 | 627 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2006 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2531 | 0.070 |
Why?
|
Subclavian Artery | 1 | 2008 | 138 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3683 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1883 | 0.070 |
Why?
|
Atrial Flutter | 1 | 2009 | 253 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1712 | 0.070 |
Why?
|
Middle Aged | 20 | 2024 | 223233 | 0.070 |
Why?
|
Femoral Artery | 1 | 2011 | 827 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3387 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2011 | 934 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4186 | 0.070 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2009 | 511 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2011 | 463 | 0.070 |
Why?
|
Equipment Failure | 1 | 2009 | 585 | 0.070 |
Why?
|
Regional Blood Flow | 1 | 2009 | 1479 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2022 | 15925 | 0.060 |
Why?
|
ROC Curve | 3 | 2012 | 3618 | 0.060 |
Why?
|
Risk Factors | 8 | 2024 | 74886 | 0.060 |
Why?
|
United States | 10 | 2025 | 72971 | 0.060 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 556 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39317 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2015 | 1321 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2011 | 843 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2021 | 15824 | 0.060 |
Why?
|
Risk Assessment | 5 | 2024 | 24299 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7063 | 0.060 |
Why?
|
Risk | 3 | 2020 | 9606 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2215 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2009 | 773 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2012 | 858 | 0.060 |
Why?
|
Smoking | 1 | 2001 | 9081 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1592 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12986 | 0.060 |
Why?
|
Sick Sinus Syndrome | 1 | 2023 | 51 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8736 | 0.050 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2023 | 55 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2025 | 188 | 0.050 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 537 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2009 | 1243 | 0.050 |
Why?
|
Catheterization | 1 | 2008 | 1430 | 0.050 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 700 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2012 | 2163 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4210 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14672 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2817 | 0.050 |
Why?
|
Propensity Score | 2 | 2022 | 1971 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2021 | 81659 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2598 | 0.050 |
Why?
|
Australia | 1 | 2025 | 1263 | 0.050 |
Why?
|
Prevalence | 3 | 2012 | 15851 | 0.050 |
Why?
|
Guatemala | 1 | 2001 | 161 | 0.040 |
Why?
|
Superinfection | 1 | 2021 | 61 | 0.040 |
Why?
|
Preoperative Care | 2 | 2020 | 2252 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10092 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2476 | 0.040 |
Why?
|
Independent Living | 1 | 2024 | 584 | 0.040 |
Why?
|
Heart Rate | 2 | 2009 | 4209 | 0.040 |
Why?
|
Cohort Studies | 5 | 2021 | 41718 | 0.040 |
Why?
|
Incidence | 3 | 2021 | 21526 | 0.040 |
Why?
|
Acute Disease | 2 | 2007 | 7236 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2008 | 1506 | 0.040 |
Why?
|
Sex Factors | 2 | 2021 | 10622 | 0.040 |
Why?
|
Sex Chromosomes | 1 | 1979 | 101 | 0.040 |
Why?
|
Adult | 10 | 2024 | 223317 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29963 | 0.040 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 192 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18401 | 0.040 |
Why?
|
Sus scrofa | 1 | 2020 | 430 | 0.040 |
Why?
|
Prospective Studies | 4 | 2025 | 54886 | 0.040 |
Why?
|
Comorbidity | 3 | 2021 | 10582 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2815 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3700 | 0.040 |
Why?
|
Hemorrhage | 1 | 2010 | 3464 | 0.040 |
Why?
|
Odds Ratio | 1 | 2009 | 9660 | 0.030 |
Why?
|
Ethanol | 1 | 2023 | 1330 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3431 | 0.030 |
Why?
|
Observer Variation | 2 | 2013 | 2616 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13491 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2299 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2012 | 3418 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2009 | 2495 | 0.030 |
Why?
|
Sex Distribution | 1 | 2001 | 2276 | 0.030 |
Why?
|
X Chromosome | 1 | 1979 | 819 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 771 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 1979 | 527 | 0.030 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2017 | 222 | 0.030 |
Why?
|
Massachusetts | 3 | 2013 | 8890 | 0.030 |
Why?
|
Extremities | 1 | 2021 | 870 | 0.030 |
Why?
|
World Health Organization | 1 | 2001 | 1327 | 0.030 |
Why?
|
Echocardiography | 2 | 2020 | 5042 | 0.030 |
Why?
|
Blood Preservation | 1 | 1975 | 169 | 0.030 |
Why?
|
Postoperative Care | 2 | 2018 | 1480 | 0.030 |
Why?
|
Mentors | 1 | 2020 | 672 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6489 | 0.030 |
Why?
|
Shock, Septic | 1 | 2021 | 772 | 0.030 |
Why?
|
Suction | 1 | 2015 | 268 | 0.030 |
Why?
|
China | 1 | 2020 | 2394 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3717 | 0.030 |
Why?
|
Drug Industry | 1 | 2020 | 791 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2013 | 222 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2227 | 0.030 |
Why?
|
Stroke Volume | 2 | 2022 | 5618 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1240 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10393 | 0.020 |
Why?
|
Atherectomy | 1 | 2011 | 41 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4026 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2023 | 3837 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1394 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13284 | 0.020 |
Why?
|
Rural Population | 1 | 2001 | 2321 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2012 | 386 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 1975 | 1097 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1975 | 1163 | 0.020 |
Why?
|
Poverty | 1 | 2001 | 2719 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3934 | 0.020 |
Why?
|
Hyperplasia | 1 | 2012 | 1150 | 0.020 |
Why?
|
Cardiology | 1 | 2020 | 1701 | 0.020 |
Why?
|
Pedigree | 2 | 2011 | 4539 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8504 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1975 | 1308 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2012 | 795 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 26325 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3964 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1566 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3489 | 0.020 |
Why?
|
Sepsis | 1 | 2021 | 2605 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20741 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2078 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2006 | 189 | 0.020 |
Why?
|
Heart Murmurs | 1 | 2006 | 92 | 0.020 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2008 | 271 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2013 | 20169 | 0.020 |
Why?
|
Sirolimus | 1 | 2012 | 1539 | 0.020 |
Why?
|
Laser Therapy | 1 | 2011 | 1108 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5311 | 0.010 |
Why?
|
Systole | 1 | 2006 | 935 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5875 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1326 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5886 | 0.010 |
Why?
|
Lipids | 1 | 2013 | 3322 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9360 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2627 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2012 | 2131 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10815 | 0.010 |
Why?
|
Hypertension | 1 | 2021 | 8615 | 0.010 |
Why?
|
Aspirin | 1 | 2012 | 3135 | 0.010 |
Why?
|
Insurance, Health | 1 | 2012 | 2519 | 0.010 |
Why?
|
Leukemia, Lymphoid | 1 | 1979 | 307 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3370 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1979 | 361 | 0.010 |
Why?
|
Infectious Mononucleosis | 1 | 1979 | 133 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5329 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2007 | 1217 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16718 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 6000 | 0.010 |
Why?
|
Genetic Testing | 1 | 2011 | 3591 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 59980 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168965 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 89046 | 0.010 |
Why?
|
Burkitt Lymphoma | 1 | 1979 | 338 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2007 | 7871 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2012 | 4306 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1979 | 549 | 0.010 |
Why?
|
Hemorrhagic Disorders | 1 | 1975 | 34 | 0.010 |
Why?
|
Prothrombin Time | 1 | 1975 | 117 | 0.010 |
Why?
|
Freezing | 1 | 1975 | 310 | 0.010 |
Why?
|
Blood Cell Count | 1 | 1975 | 404 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1975 | 269 | 0.010 |
Why?
|
HLA Antigens | 1 | 1979 | 1334 | 0.010 |
Why?
|
Hematocrit | 1 | 1975 | 622 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1975 | 580 | 0.010 |
Why?
|
Syndrome | 1 | 1979 | 3271 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12823 | 0.010 |
Why?
|
Blood Pressure | 1 | 2006 | 8531 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 22254 | 0.010 |
Why?
|
Hemoglobins | 1 | 1975 | 1531 | 0.010 |
Why?
|
Mutation | 1 | 2011 | 30211 | 0.000 |
Why?
|
Aging | 1 | 1979 | 8729 | 0.000 |
Why?
|
Child, Preschool | 1 | 1979 | 42606 | 0.000 |
Why?
|
Child | 1 | 1979 | 80771 | 0.000 |
Why?
|